These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 15170966)
21. Effect of abnormal thyroid function on the severity of Graves' ophthalmopathy. Prummel MF; Wiersinga WM; Mourits MP; Koornneef L; Berghout A; van der Gaag R Arch Intern Med; 1990 May; 150(5):1098-101. PubMed ID: 1691908 [TBL] [Abstract][Full Text] [Related]
22. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease. Noh JY; Hamada N; Inoue Y; Abe Y; Ito K; Ito K Thyroid; 2000 Sep; 10(9):809-13. PubMed ID: 11041459 [TBL] [Abstract][Full Text] [Related]
23. Graves' ophthalmopathy evolution studied by MRI during childhood and adolescence. Antoniazzi F; Zamboni G; Cerini R; Lauriola S; Dall'Agnola A; Tatò L J Pediatr; 2004 Apr; 144(4):527-31. PubMed ID: 15069405 [TBL] [Abstract][Full Text] [Related]
24. [Sonography of the retrobulbar space in autoimmune hyperthyroidism of the Basedow type]. Schillings S; Wagner J; Franzen W; Wildmeister W Z Gesamte Inn Med; 1990 Nov; 45(22):678-83. PubMed ID: 2099028 [TBL] [Abstract][Full Text] [Related]
25. [Diagnostic difficulties in Grave's orbitopathy--case report]. Jedrzejowski M; Grzesiuk W; Szwejda E; Bar-Andziak E Pol Merkur Lekarski; 2004 Mar; 16(93):251-4. PubMed ID: 15190602 [TBL] [Abstract][Full Text] [Related]
26. Radiologically manifested accessory extraocular muscles in thyroid eye disease. Sinclair NE; Roberts MA; Hourihan MD; Walters RF; Lane CM Ophthalmic Plast Reconstr Surg; 2010; 26(4):286-8. PubMed ID: 20502362 [TBL] [Abstract][Full Text] [Related]
27. Echographic monitoring of response of extraocular muscles to irradiation in Graves' ophthalmopathy. Erickson BA; Harris GJ; Lewandowski MF; Murray KJ; Massaro BM Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):651-60. PubMed ID: 7852132 [TBL] [Abstract][Full Text] [Related]
28. The ophthalmopathy of Graves' disease. Carter JA; Utiger RD Annu Rev Med; 1992; 43():487-95. PubMed ID: 1580604 [TBL] [Abstract][Full Text] [Related]
32. [Assessment of autoimmune disease activity in endocrine orbitopathy: comparison of SPECT using 99m-Tc-DTPA or 99m-Tc-depreotide and MRI scores]. Galuska L; Nagy E; Szúcs-Farkas Z; Szabados L; Garai I; Szabó J; Varga J; Leövey A Orv Hetil; 2003 Oct; 144(41):2017-22. PubMed ID: 14631894 [TBL] [Abstract][Full Text] [Related]
38. Prevalence of increased intraocular pressure in Graves' disease--evidence of frequent subclinical ophthalmopathy. Gamblin GT; Harper DG; Galentine P; Buck DR; Chernow B; Eil C N Engl J Med; 1983 Feb; 308(8):420-4. PubMed ID: 6687400 [TBL] [Abstract][Full Text] [Related]
39. Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy. Laurberg P; Berman DC; Andersen S; Bülow Pedersen I Thyroid; 2011 Sep; 21(9):951-6. PubMed ID: 21834677 [TBL] [Abstract][Full Text] [Related]